AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 10 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2024. The put-call ratio across all filers is - and the average weighting 2.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 600,000 | $8,436,000 | 5.68% |
| Vivo Capital, LLC | 3,972,099 | $55,847,712 | 5.16% |
| Tri Locum Partners LP | 1,189,518 | $16,724,623 | 4.23% |
| Knott David M Jr | 333,000 | $4,682 | 1.87% |
| MPM BioImpact LLC | 783,242 | $11,012,383 | 1.71% |
| SCHULHOFF & CO INC | 137,000 | $1,926,220 | 0.87% |
| 1620 INVESTMENT ADVISORS, INC. | 1,000 | $14,060 | 0.01% |
| Ameritas Investment Partners, Inc. | 9,055 | $127,313 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $16 | 0.00% |
| CWM, LLC | 99 | $1 | 0.00% |
External links
This page lists AVADEL PHARMACEUTICALS PLC's shareholders in Q2 2024. To view AVADEL PHARMACEUTICALS PLC's shareholder history, click here.